Back to search

Spain· ES:78372

MOMETASONA ALMIRALL 1 MG/G EMULSION CUTANEA

A mometasone product containing mometasona, registered in Spain by Almirall Hermal Gmbh. The same ATC class is registered in 15 of our 19 countries.

ATC D07AC13

Checked against AEMPS CIMA (Spain) on

Informational only — not a medical device.

SOURCE REGISTER · ESAEMPS CIMA (Spain)normalisedMOMETASONA ALMIRALL 1 MG/G EMULSION C…ATCD07AC13REGISTER NO.ES:78372PACKS LISTED0CHECKEDSeptember 12, 2026

Where it is registered

Mometasone is registered in 15 of 19 countries.

Countries holding a registration under ATC D07AC13 (mometasone), each read from that country’s own register.

  • This record: Spain, from AEMPS CIMA (Spain)
  • 9 of them publish a price we can compare per daily dose

Mometasone · ATC D07AC13

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

AEMPS CIMA (Spain)
Active substance
mometasona
Manufacturer
Almirall Hermal Gmbh
Country
Spain (ES)
ATC code
D07AC13
ATC class
Mometasone
Defined daily dose
1 mg, T
Reimbursed
Not published by this register
Source register
AEMPS CIMA (Spain)
Last checked
September 12, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Mometasone in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All mometasone products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Asmanex Twisthaler, Elocon
  • Belgium · Asmanex Twisthaler, Elocom
  • Bulgaria · Блоктимо, Елоком
  • Cyprus · Elocon, Movesan
  • Czechia · Asmanex, Elocom
  • Germany · Allergo-Momelind, Asmanex Twisthaler
  • Denmark · Aphiahsone, Asmanex Twisthaler
  • Estonia · Breso, Elocon
  • Finland · Asmanex Twisthaler, Demoson
  • France · Asmanex Twisthaler, Mometasone Arrow
  • United Kingdom (Northern Ireland) · Asmanex Twisthaler, Clarinaze Allergy Control
  • Greece · Asmanex Twisthaler, Elocon
  • Croatia · Elocom, Momanose
  • Hungary · Azocutan, Elocom
  • Ireland · Asmanex Twisthaler, Elocon
  • Iceland · Elocon, Kalmente
  • Italy · Arinit, Asmanex
  • Lithuania · Breso, Elocon
  • Luxembourg · Elocom, Monovo
  • Latvia · Breso, Elocon
  • Malta · Elocon, Nasonex
  • Netherlands · Elocon, Elocon Vet
  • Norway · Asmanex Twisthaler, Elocon
  • Poland · Aleric Spray, Edelan
  • Portugal · Asmanex Twisthaler, Desdek
  • Romania · Elocom, Furoat De Mometazonă Cipla
  • Sweden · Aphiahsone, Asmanex Twisthaler
  • Slovenia · Asmanex Twisthaler, Elocom
  • Slovakia · Asmanex, Elocom

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/0c858d79-d074-4319-85cb-4421f42abe50
GET /v1/drugs/0c858d79-d074-4319-85cb-4421f42abe50?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cpresc": "Medicamento Sujeto A Prescripción Médica",
  "estado": "{\"aut\":1389654000000,\"rev\":1629292157000}",
  "nregistro": "78372",
  "substance": "mometasona"
}

See everything about mometasone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.